# Ritz Venture Capital

> Ritz Venture Capital is a VC fund in Singapore backing Biotechnology, B2B and SaaS. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 5
- Last investment: Aug 2025
- Lead investor: 40%
- Last updated: Aug 2026
- Website: https://www.ritzventurecapital.com/

Ritz Venture Capital is a VC fund in Singapore focused on Biotechnology and B2B. Ritz Venture Capital invests in early-stage technology companies with the aim of supporting STEM talents and nurturing innovation for a sustainable future.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4.5M–$12M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| B2B | 1 | 20% |
| SaaS | 1 | 20% |
| Battery | 1 | 20% |
| FinTech | 1 | 20% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 3 | 60% |
| Series A | 2 | 40% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 60% |
| Singapore | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Turnkey Lender | Turnkey Lender provides a cloud-based, AI-powered lending automation platform that enables lenders to digitize the loan lifecycle. The company offers AI-powered end-to-end lending automation for digital and embedded lenders. Its solution delivers decisioning, origination, servicing, collections, and compliance in one unified system, helpingfinancial institutions and fintechs scale efficiently while staying compliant. |  | Venture - Series Unknown | Aug 28, 2025 |  |
| Singrow | Singrow is a precision agriculture company. Using plant science in CRISPR-Cas9 technology, holistic farming system, smart sensors, data science to build the future farms. 1. Faster harvest 2. Higher yield rate 3. Increase value | $4.5M | Series A | Aug 18, 2025 |  |
| UNIGRID | Unigrid develops sodium-ion batteries designed for energy storage and e-mobility applications. The company focuses on creating sustainable battery solutions that utilize abundant materials, promoting environmental responsibility. Unigrid's products aim to provide efficient energy storage options suitable for various industries, includingrenewable energy and electric vehicles. The team is dedicated to addressing current energy challenges through innovative technology, facilitating a transition towards more sustainable energy practices. Unigrid's approach emphasizes both performance and safety, making its battery solutions a practical choice for modern energy needs. | $12M | Series A | Jun 13, 2024 |  |
| KNOREX | Knorex is a technology company that provides programmatic advertising products and solutions to marketers to connect in real-time with the desired audience worldwide through the industry's widest deep connectivity to leading marketing channels including social media, search, connected TVs/OTTs, video, audio, display/native, andemail, all in one place.With its cross-channel marketing automation platform, Knorex XPO unifies advertising across multiple channels and enables marketers to deliver personalized marketing messages at the right moment to the right audience whether they are on mobile or on the Web. Through a multi-layered data-driven approach, XPO simplifies and automates digital advertising execution and optimization to deliver measurable performance powered by machine-learning/AI. |  | Venture - Series Unknown | Jul 25, 2023 |  |
| ACM | At ACM Biolabs, we are focused on developing novel vaccines and antibodies using our proprietary artificial cell membrane ("ACM"​) technology. We are able to incorporate functional, folded membrane proteins into the artificial cell membranes which keep them stable, allowing them to induce a strong immune reaction. We have demonstratedefficacy via both injected and oral dosages using synthesized membrane proteins and have a growing pipeline of vaccine and antibodies.The company is headquartered in Singapore, and has been operational since 2013. | $6.8M | Venture - Series Unknown | Sep 22, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [AgFunder](https://shizune.co/investors/profile/agfunder) — VC Fund, 1 deal together
- [Cyanhill Capital](https://shizune.co/investors/profile/cyanhill-capital) — VC Fund, 1 deal together
- [DEG](https://shizune.co/investors/profile/deg) — VC Fund, 1 deal together
- [Easternwind International](https://shizune.co/investors/profile/easternwind-international) — VC Fund, 1 deal together
- [FINCA International](https://shizune.co/investors/profile/finca-inter-national) — VC Fund, 1 deal together
- [Investors Finc](https://shizune.co/investors/profile/investors-finc) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Singapore](https://shizune.co/investors/biotechnology-investors-singapore)
- [Biotechnology VC Funds in Singapore](https://shizune.co/investors/biotechnology-vc-funds-singapore)
- [Biotech Investors in Singapore](https://shizune.co/investors/biotech-investors-singapore)
- [Biotech VC Funds in Singapore](https://shizune.co/investors/biotech-vc-funds-singapore)
- [Medical Investors in Singapore](https://shizune.co/investors/medical-investors-singapore)
- [Medical VC Funds in Singapore](https://shizune.co/investors/medical-vc-funds-singapore)

## FAQ

### What does Ritz Venture Capital invest in?

Ritz Venture Capital invests primarily in Biotechnology, B2B and SaaS startups, most often at Venture - Series Unknown and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Ritz Venture Capital's check size?

Ritz Venture Capital typically joins rounds of $4.5M–$12M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ritz Venture Capital participates in.

### When did Ritz Venture Capital last invest?

The most recent investment recorded for Ritz Venture Capital closed in Aug 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co